Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Synovial Membrane | 2 | 2008 | 20 | 0.530 |
Why?
|
| Dronabinol | 3 | 2009 | 32 | 0.430 |
Why?
|
| Synovial Fluid | 3 | 2008 | 29 | 0.320 |
Why?
|
| Eicosanoids | 1 | 2008 | 25 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2009 | 172 | 0.280 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2015 | 24 | 0.240 |
Why?
|
| Fibroblasts | 3 | 2009 | 387 | 0.230 |
Why?
|
| Arthritis | 1 | 2005 | 53 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 205 | 0.210 |
Why?
|
| Knee Joint | 1 | 2005 | 297 | 0.190 |
Why?
|
| Antirheumatic Agents | 2 | 2015 | 220 | 0.150 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 75 | 0.130 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 47 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2015 | 72 | 0.110 |
Why?
|
| Rheumatology | 1 | 2015 | 67 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2008 | 335 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1537 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 614 | 0.080 |
Why?
|
| Lipoxins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Prostaglandins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Arachidonic Acid | 1 | 2008 | 34 | 0.070 |
Why?
|
| Cannabinoids | 1 | 2009 | 41 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 1 | 2008 | 32 | 0.070 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 7 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2007 | 76 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 31 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 107 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2005 | 88 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2151 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2005 | 205 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2005 | 321 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2005 | 661 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 839 | 0.050 |
Why?
|
| Phenotype | 1 | 2005 | 1199 | 0.040 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 385 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 895 | 0.040 |
Why?
|
| Humans | 6 | 2015 | 63292 | 0.030 |
Why?
|
| Spondylarthropathies | 1 | 2015 | 4 | 0.030 |
Why?
|
| Etanercept | 1 | 2015 | 32 | 0.030 |
Why?
|
| Adalimumab | 1 | 2015 | 30 | 0.030 |
Why?
|
| Infliximab | 1 | 2015 | 50 | 0.030 |
Why?
|
| Spondylarthritis | 1 | 2015 | 39 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 102 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2015 | 188 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 548 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 462 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2015 | 375 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 474 | 0.020 |
Why?
|
| Peritonitis | 1 | 2009 | 36 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 16 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2007 | 29 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cartilage | 1 | 2007 | 35 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 156 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 376 | 0.020 |
Why?
|
| Mice | 2 | 2009 | 10816 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 1977 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7825 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 2107 | 0.010 |
Why?
|
| Animals | 2 | 2009 | 20622 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2179 | 0.010 |
Why?
|
| Male | 1 | 2009 | 29820 | 0.000 |
Why?
|